Mr. Luc Mongeau reports

CANOPY GROWTH APPOINTS MILES WORNE AS MANAGING DIRECTOR OF EUROPEAN MARKETS

Canopy Growth Corp. has appointed Miles Worne as managing director of European markets, effective Aug. 11, 2025.

Mr. Worne will be responsible for leading the company's commercial operations and go-to-market execution across the region. His appointment reflects a strategic investment in Europe, where Canopy Growth aims to deepen its presence in established medical markets and build the capabilities needed to support long-term expansion as new opportunities emerge.

"Europe represents one of the most compelling long-term growth opportunities for Canopy Growth," said Luc Mongeau, chief executive officer. "With a strong commercial background and deep experience in the cannabis sector navigating complex markets, Miles is well positioned to help scale our presence in the region and support the delivery of our global medical strategy."

Mr. Worne is an experienced commercial leader with over 20 years of global experience across the cannabis, health care and consumer sectors. Most recently, he served as president of Curaleaf International, where he led the expansion of the company's European medical cannabis operations. His background includes senior leadership roles in Europe, North America and Asia at Glanbia Performance Nutrition and SlimFast International. Mr. Worne brings a strong record of driving growth, building teams and scaling businesses in regulated markets.

"I'm pleased to join Canopy Growth during a time of developing momentum in Europe," said Miles Worne. "Canopy Growth is uniquely positioned with high-quality supply, trusted medical brands and a growing presence in priority markets. I look forward to working with the team to build on this foundation and deliver meaningful growth in the region."

The company's European operations are supported by European Union (EU) GMP-certified (good manufacturing practices) supply from its Kincardine, Ont., facility, enhanced processing and distribution capabilities at its St. Leon-Rot facility in Germany, and a global supply chain infrastructure designed to meet the needs of patients and partners across the region.

About Canopy Growth Corp.

Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives.

Through an unwavering commitment to consumers, Canopy Growth delivers innovative products from owned and licensed brands, including Tweed, 7Acres, Doja, Deep Space and Claybourne, as well as category defining vaporization devices by Storz & Bickel. In addition, Canopy Growth serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.

Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the United States THC (tetrahydrocannabinol) market through an unconsolidated, non-controlling interest in Canopy USA LLC. Canopy USA's portfolio includes ownership of Acreage Holdings Inc., a vertically integrated multistate cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Wellness LLC, The Cima Group LLC and Mountain High Products LLC, a leading North American edibles brand, and majority ownership of Lemurian Inc., a California-based producer of high-quality cannabis extracts and clean vape technology.

Canopy Growth is shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use and a focus on enhancing the communities where people live and work, Canopy Growth is paving the way for a better understanding of all that cannabis can offer.